Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline-Reference-Cited by-同舟云学术

Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracycline

Published:1989-09 Issue:2 Volume:54 Page:113-121
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Rolland Alain

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference65 articles.

1. Enhancement of adriamycin antitumor activity by its binding with an intracellular sustained-release form, polymethacrylate nanospheres, in U-937 cells;Astier;Cancer Res.,1988

2. Analysis of antitumor antibiotics by high pressure liquid chromatography (HPLC);Aszalos;J. Liquid Chromatogr.,1984

3. Anthracycline assay by high-pressure liquid chromatography;Averbuch;J. Pharm. Sci.,1981

4. Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay;Bachur;Clin. Pharmacol. Ther.,1976

5. Rapid determination of doxorubicin and its fluorescent metabolites by high-pressure liquid chromatography;Baurain;Anal. Biochem.,1979

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart chitosan nanogel for targeted doxorubicin delivery, ensuring precise release, and minimizing side effects in Ehrlich ascites carcinoma-bearing mice;International Journal of Biological Macromolecules;2024-05

2. Continuous fractionation of nanoparticles based on their magnetic properties applying simulated moving bed chromatography;Separation and Purification Technology;2021-03

3. Fabrication, Optimization and Characterization of Paclitaxel and Spirulina Loaded Nanoparticles for Enhanced Oral Bioavailability;Current Nanoscience;2020-10-05

4. Characterization of pharmaceutical nanocarriers: in vitro and in vivo studies;Nanomaterials for Drug Delivery and Therapy;2019

5. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin;Journal of Controlled Release;2013-11